The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Treatment of Benzodiazepine Dependence
Abstract
Long-term use of benzodiazepines can lead to dependence. Symptoms of withdrawal include anxiety, irritability, confusion, seizures, and sleep disorders. Withdrawal management relies on the use of a single agent (diazepam) and gradual dose reduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, use of these medications is associated with an increased risk of adverse events, including falls, motor vehicle accidents, cognitive impairment, delirium, overdose, and death, particularly when BZDs are used in combination with central nervous system (CNS) depressants such as alcohol or opioids.1–3”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [2]
In the citing paper
“Patients can experience life-threatening withdrawal symptoms with abrupt or rapid discontinuation of BZDs, and some patients experience significant symptoms even with gradual dose reduction.2,20,68”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [2]
In the citing paper
“Most existing guidance recommend a flexible approach to tapering, reducing the dose at a rate dictated by each patient’s ability to tolerate withdrawal symptoms and allowing the process to take as long as patients need.2,59,69,79,80,100–102”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [2]
In the citing paper
“Sleep disturbance is a common symptom during BZD tapering and may contribute to symptom exacerbation of underlying mood or psychotic disorders.2,164,165”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [2]
In the citing paper
“BZD tapering may exacerbate or cause recurrence of psychiatric symptoms that may warrant more intensive clinical oversight.2,150”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [2]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
The Transtheoretical Model of Health Behavior Change.
Prochaska, J. O., & Velicer, W. F. (1997) · American Journal of Health Promotion · doi:10.4278/0890-1171-12.1.38 · Cited by 7,782
(2013) · Cited by 2,393
Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family
Schofield, P. R., Darlison, M. G., Fujita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., et al. (1987) · Nature · doi:10.1038/328221a0 · Cited by 1,622
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1172 · Cited by 1,098
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Research works printed but not linked: 7
- Amato L, 2010, Cochrane Database Syst Rev, CD005063
- Berryman SN, 2012, Medsurg Nurs, 21, 129
- Ashton H. Benzodiazepine abuse. In: Caan W, de Belleroche J, eds. Drink, drugs and dependence: from science to clinical practice. London: Routledge, 2002:197-212.
- Soyka M, 1988, Nervenarzt, 59, 744
- Darker CD, 2015, Cochrane Database Syst Rev, 5, CD009652
- Hunt GE, 2013, Cochrane Database Syst Rev, 10, CD001088
- Baillie AL, Sannibale C. Anxiety and drug and alcohol problems. In: Baker A, Velleman R, eds. Mental health and drug and alcohol problems. London: Routledge, 2007:197-217.
Cited by
Delirium Tremens: Assessment and Management
Grover, S., & Ghosh, A. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.012 · Cited by 416
“Withdrawal from benzodiazepines has a lot of common features (of alcohol withdrawal) like tremor, agitation, perceptual disturbances, seizure, and even delirium.(39) Moreover, it might also influence the dose of benzodiazepine to be used for the treatment of DT.”
BackgroundThe Diagnosis and Treatment of Anxiety Disorders
Ströhle, A., Gensichen, J., & Domschke, K. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0611 · Cited by 186
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Lähteenvuo, M., & Tiihonen, J. (2021) · Drugs · doi:10.1007/s40265-021-01556-4 · Cited by 216
Inpatient Addiction Consult Service
Weinstein, Z., Wakeman, S. E., & Nolan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.03.001 · Cited by 140
Fluyau, D., Revadigar, N., & Manobianco, B. E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317753340 · Cited by 109
Metadata
- Authors
- Soyka, M.
- Affiliations
- Privatklinik Meiringen (CH)
- Corresponding author
- Soyka, Michael
- ORCID
- Soyka, Michael
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-03-23
- Volume
- 376
- Issue
- 12
- Pages
- 1147-1157
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2598429061
- Semantic Scholar
- 44418a0e25647425877c97f78d9d4c9dcd0f2c84
- Cited by
- 465
- References
- 66
- Citations by year
- 2026: 38 · 2025: 33 · 2024: 56 · 2023: 74 · 2022: 64 · 2021: 61 · 2020: 43 · 2019: 60 · 2018: 29 · 2017: 6
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine dependence, benzodiazepine withdrawal, diazepam, gradual dose reduction, withdrawal symptoms, seizures, sleep disorders, anxiety
- MeSH terms
- Benzodiazepines, Diagnosis, Differential, Diazepam, Humans, Hypnotics and Sedatives, Psychotherapy, Receptors, GABA-A, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Benzodiazepine Dependence. https://app.cochat.ai/papers/10.1056/nejmra1611832
- The paper
- Soyka, M. (2017). Treatment of Benzodiazepine Dependence. New England Journal of Medicine. https://doi.org/10.1056/nejmra1611832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.